This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Henry Schein Climbs To #292 On The FORTUNE 500A®

MELVILLE, N.Y., June 2, 2014 /PRNewswire/ -- Henry Schein, Inc. (NASDAQ: HSIC), the world's largest provider of health care products and services to office-based dental, animal health and medical practitioners, announced today that it has climbed to #292 on the FORTUNE 500® ranking of America's largest corporations, marking its 10th anniversary as a FORTUNE 500 company.  The Company was ranked #296 on the 2013 list.

Henry Schein had net sales in 2013 of $9.6 billion, up from $4.1 billion in 2004 when it first debuted on the FORTUNE 500 at #497.  Since Henry Schein became a public company in 1995, the Company's revenues have grown at a compound annual rate of approximately 16 percent.

The FORTUNE 500 list is an annual ranking of America's largest corporations based on total revenues for their respective fiscal years. Included in the survey are companies that are incorporated in the U.S. and operate in the U.S. and file financial statements with a government agency.

"Our continued climb up the Fortune 500 rankings for a decade underscores the soundness of our long-term strategic vision for the Company," said Stanley M. Bergman, Chairman of the Board and Chief Executive Officer of Henry Schein.  "Our continued global growth is the result of the shared commitment and values of nearly 17,000 Team Schein Members, who are dedicated to providing our customers with the very best solutions and service, and to continually raising the bar for our Company's performance year after year."

Henry Schein has also been a FORTUNE Most Admired company for 13 consecutive years.  In 2014, the Company ranked #1 on the 2014 FORTUNE Most Admired list in the Wholesalers: Health Care industry category, and first in each of the nine sub-categories used to create the rankings, which are: Innovation, People Management, Use of Corporate Assets, Social Responsibility, Quality of Management, Financial Soundness, Long-Term Investment, Quality of Products/Services, and Global Competitiveness.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,813.39 +1.20 0.01%
S&P 500 2,088.87 -0.27 -0.01%
NASDAQ 5,116.1430 +13.3350 0.26%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs